Sectors
SGP
SpyGlass Pharma, Inc.
26.10
2 x 19.14
2 x 33.03
bid
ask
-
0.32
1.21%
2 @ 07:30 PM
26.10 +0.00 (0.00%)
| Ytd | -1.14% | |
| 1y | -1.14% |
25.62
day range
26.64
17.06
52 week range
32.44
| Open | 26.42 | Prev Close | 26.42 | Low | 25.62 | High | 26.64 | Mkt Cap | 872.99M |
| Vol | 64.81K | Avg Vol | 114.93K | EPS | -1.66 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 22.52 | 200-d Avg | 23.44 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 21.97M | ||
| Research and Development Expense | 10.94M | ||
| Selling, General and Administrative Expense | 11.03M | ||
| Operating Income | -21.97M | ||
| Net Income | -19.86M | ||
| Net Income Common Stock | -19.86M | ||
| Net Income Common Stock (USD) | -19.86M | ||
| Consolidated Income | -19.86M | ||
| Earnings per Basic Share | -0.59 | ||
| Earnings per Basic Share (USD) | -0.59 | ||
| Earnings per Diluted Share | -0.59 | ||
| Earning Before Interest & Taxes (EBIT) | -19.86M | ||
| Earning Before Interest & Taxes (USD) | -19.86M | ||
| Weighted Average Shares | 33.44M | ||
| Weighted Average Shares Diluted | 33.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 223.14M | ||
| Cash and Equivalents (USD) | 223.14M | ||
| Investments | 11.04M | ||
| Investments Current | 11.04M | ||
| Trade and Non-Trade Receivables | 678.00K | ||
| Current Assets | 236.46M | ||
| Property, Plant & Equipment Net | 6.21M | ||
| Total Assets | 243.43M | ||
| Total Debt | 1.63M | ||
| Current Liabilities | 9.44M | ||
| Debt Non-Current | 1.63M | ||
| Total Liabilities | 11.07M | ||
| Accumulated Retained Earnings (Deficit) | -138.41M | ||
| Shareholders Equity | 232.36M | ||
| Shareholders Equity (USD) | 232.36M | ||
| Assets Non-Current | 6.97M | ||
| Total Debt (USD) | 1.63M | ||
| Liabilities Non-Current | 1.63M | ||
| Trade and Non-Trade Payables | 4.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 404.00K | ||
| Net Cash Flow from Financing | 13.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -15.76M | ||
| Capital Expenditure | -1.93M | ||
| Issuance (Purchase) of Equity Shares | 31.00K | ||
| Net Cash Flow from Investing | -933.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 999.00K | ||
| Net Cash Flow from Operations | -14.84M | ||
| Share Based Compensation | 2.09M | ||